Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.36 AUD | +7.46% | +12.50% | +75.61% |
01/05 | Dimerix Secures Pediatric Plan Approval in the UK for Kidney Disease Medication | MT |
22/04 | Dimerix Posts AU$35.2 Million Cash, AU$3.3 Million Operating Cash Outflows for March Quarter | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+75.61% | 131M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- DXB Stock
- News Dimerix Limited
- Dimerix Secures Australian Ethics Approval for Phase 3 Study of COVID-19 Drug Candidate; Shares Jump 7%